Literature DB >> 6267132

How complement kills E. coli. I. Location of the lethal lesion.

S D Wright, R P Levine.   

Abstract

We have studied the action of human complement (C) on E. coli membranes. We find, as have others, that C disrupts the outer membrane (OM), allowing the release of periplasmic proteins. In addition, we have found 1) that in the complete absence of lysozyme, C damages the inner membrane (IM), 2) IM damage is different from OM damage in that only small molecules traverse a damaged IM whereas macromolecules traverse damaged OM, 3) IM damage and OM damage occur with identical kinetics and dose response, suggesting that IM and OM damage are closely coupled events, and 4) upon the addition of purified C8 and C9 to the washed cellular intermediate, E. coli C 1-7, both IM and OM are damaged coordinately. These results, taken together, suggest that C damages E. coli membranes by acting at a site contiguous with both membranes. We speculate that C may simultaneously gain access to both membranes by acting at the junctions between IM and OM.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267132

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Growth phase influences complement resistance of Bordetella pertussis.

Authors:  Michael G Barnes; Alison A Weiss
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 2.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

3.  Does complement kill E. coli by producing transmural pores?

Authors:  J Born; S Bhakdi
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

4.  Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.

Authors:  J R Dankert; A F Esser
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

5.  Formation of transmural complement pores in serum-sensitive Escherichia coli.

Authors:  S Bhakdi; G Kuller; M Muhly; S Fromm; G Seibert; J Parrisius
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.

Authors:  N L Schiller; M J Alazard; R S Borowski
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.

Authors:  E J Heffernan; S Reed; J Hackett; J Fierer; C Roudier; D Guiney
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo.

Authors:  R P Darveau; M D Cunningham; C L Seachord; L Cassiano-Clough; W L Cosand; J Blake; C S Watkins
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.

Authors:  T A Russo; M C Moffitt; C H Hammer; M M Frank
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Nucleotide sequence analysis of the complement resistance gene from plasmid R100.

Authors:  R T Ogata; C Winters; R P Levine
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.